|

DNA Analysis of Blood and Tissue from Patients with Lung Cancer

RECRUITINGSponsored by Massachusetts General Hospital
Actively Recruiting
SponsorMassachusetts General Hospital
Started2005-09
Est. completion2026-09
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT00471978

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
DISEASE CHARACTERISTICS:

* Patient:

  * Newly diagnosed primary lung cancer

    * Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified

EXCLUSIONS:

Vulnerable populations are excluded. Patients with metastasis from another site to lung or mesothelioma are excluded.

Conditions2

CancerLung Cancer

Locations2 sites

Massachusetts General Hospital
Boston, Massachusetts, 02114
Clinical Trials Office - Massachusetts General Hospital877-726-5130
Harvard School of Public Health
Boston, Massachusetts, 02115
David C. Christiani, MD617-726-9274

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.